Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

GLP-1 and analogues studied for diabetes

June 13, 1997

rIGF-1 + insulin improves metabolic control in IDDM patients

June 13, 1997

ACE inhibitors for diabetes

June 13, 1997

A wealth of clinical data on pramlintide presented at diabetes congress

June 12, 1997

Ergoset clinical study results presented at diabetes congress

June 12, 1997

M-16049: hypoglycemic agent and aldose reductase inhibitor

June 12, 1997

Otsuka AGE inhibitor prevents progression of diabetic nephropathy in animal model

June 12, 1997

Novel site of action for chimeric insulin-releasing peptide

June 12, 1997

BRL-48482 has potential for reducing cardiovascular risk in NIDDM

June 12, 1997

Phase III results for AY-4166

June 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...